Banco Santander S.A. Purchases 108,306 Shares of CVS Health Corp (NYSE:CVS)

Banco Santander S.A. lifted its position in CVS Health Corp (NYSE:CVS) by 204.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 161,385 shares of the pharmacy operator’s stock after buying an additional 108,306 shares during the period. Banco Santander S.A.’s holdings in CVS Health were worth $10,179,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Nuveen Asset Management LLC lifted its position in CVS Health by 16,194.7% during the second quarter. Nuveen Asset Management LLC now owns 12,112,044 shares of the pharmacy operator’s stock valued at $659,986,000 after purchasing an additional 12,037,713 shares during the period. Morgan Stanley lifted its position in CVS Health by 12.8% during the second quarter. Morgan Stanley now owns 13,765,635 shares of the pharmacy operator’s stock valued at $750,088,000 after purchasing an additional 1,560,142 shares during the period. Macquarie Group Ltd. lifted its position in CVS Health by 10.9% during the second quarter. Macquarie Group Ltd. now owns 13,905,440 shares of the pharmacy operator’s stock valued at $757,707,000 after purchasing an additional 1,372,275 shares during the period. Prudential PLC lifted its position in CVS Health by 54.8% during the second quarter. Prudential PLC now owns 3,737,874 shares of the pharmacy operator’s stock valued at $203,137,000 after purchasing an additional 1,323,366 shares during the period. Finally, Vanguard Group Inc. lifted its position in CVS Health by 1.2% during the second quarter. Vanguard Group Inc. now owns 102,367,899 shares of the pharmacy operator’s stock valued at $5,578,027,000 after purchasing an additional 1,167,143 shares during the period. Hedge funds and other institutional investors own 75.92% of the company’s stock.

CVS opened at $72.82 on Thursday. The company has a current ratio of 0.92, a quick ratio of 0.61 and a debt-to-equity ratio of 1.32. CVS Health Corp has a 1-year low of $51.72 and a 1-year high of $82.15. The company has a market capitalization of $94.28 billion, a PE ratio of 10.29, a PEG ratio of 1.57 and a beta of 0.86. The firm’s 50 day simple moving average is $65.34 and its two-hundred day simple moving average is $58.93.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.84 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.77 by $0.07. CVS Health had a net margin of 1.83% and a return on equity of 15.45%. The business had revenue of $64.81 billion for the quarter, compared to the consensus estimate of $62.99 billion. During the same period last year, the firm earned $1.73 earnings per share. The company’s quarterly revenue was up 36.5% on a year-over-year basis. Equities analysts forecast that CVS Health Corp will post 7.01 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Monday, November 4th. Shareholders of record on Thursday, October 24th were given a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.75%. CVS Health’s payout ratio is presently 28.25%.

CVS has been the topic of a number of research analyst reports. Raymond James increased their price objective on shares of CVS Health from $75.00 to $80.00 and gave the company a “strong-buy” rating in a research report on Thursday, November 7th. Evercore ISI set a $63.00 price objective on shares of CVS Health and gave the company a “buy” rating in a research report on Wednesday, August 7th. Morgan Stanley increased their price objective on shares of CVS Health from $74.00 to $77.00 and gave the company an “overweight” rating in a research report on Thursday, September 26th. SunTrust Banks increased their price objective on shares of CVS Health to $85.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Finally, UBS Group restated a “buy” rating and set a $78.00 price objective on shares of CVS Health in a research report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company. CVS Health presently has an average rating of “Buy” and an average price target of $77.59.

In other CVS Health news, EVP Troyen A. Brennan sold 23,604 shares of the stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $68.00, for a total value of $1,605,072.00. Following the transaction, the executive vice president now directly owns 107,921 shares in the company, valued at $7,338,628. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Eva C. Boratto sold 8,130 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $65.00, for a total transaction of $528,450.00. Following the completion of the transaction, the chief financial officer now owns 55,273 shares in the company, valued at $3,592,745. The disclosure for this sale can be found here. Insiders sold 49,437 shares of company stock worth $3,248,811 over the last quarter. Insiders own 0.53% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Further Reading: How is inflation measured?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.